Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Granholm, A; Kjær, MBN; Munch, MW; Myatra, SN; Vijayaraghavan, BKT; Cronhjort, M; Wahlin, RR; Jakob, SM; Cioccari, L; Vesterlund, GK; Meyhoff, TS; Helleberg, M; Møller, MH; Benfield, T; Venkatesh, B; Hammond, NE; Micallef, S; Bassi, A; John, O; Jha, V; Kristiansen, KT; Ulrik, CS; Jørgensen, VL; Smitt, M; Bestle, MH; Andreasen, AS; Poulsen, LM; Rasmussen, BS; Brøchner, AC; Strøm, T; Møller, A; Khan, MS; Padmanaban, A; Divatia, JV; Saseedharan, S; Borawake, K; Kapadia, F; Dixit, S; Chawla, R; Shukla, U; Amin, P; Chew, MS; Wamberg, CA; Bose, N; Shah, MS; Darfelt, IS; Gluud, C; Lange, T; Perner, A

File(s) not publicly available

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Version 2 2024-06-04, 02:31

Version 1 2023-02-28, 02:40

journal contribution

posted on 2024-06-04, 02:31 authored by A Granholm, MBN Kjær, MW Munch, SN Myatra, BKT Vijayaraghavan, M Cronhjort, RR Wahlin, SM Jakob, L Cioccari, GK Vesterlund, TS Meyhoff, M Helleberg, MH Møller, T Benfield, B Venkatesh, NE Hammond, S Micallef, A Bassi, O John, V Jha, KT Kristiansen, CS Ulrik, VL Jørgensen, M Smitt, MH Bestle, AS Andreasen, LM Poulsen, BS Rasmussen, AC Brøchner, T Strøm, A Møller, MS Khan, A Padmanaban, JV Divatia, S Saseedharan, K Borawake, F Kapadia, S Dixit, R Chawla, U Shukla, P Amin, MS Chew, CA Wamberg, N Bose, MS Shah, IS Darfelt, C Gluud, T Lange, A Perner

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

History

Journal

Intensive Care Medicine

Volume

48

Pagination

580-589

Location

United States

Publisher DOI

https://doi.org/10.1007/s00134-022-06677-2

ISSN

0342-4642

eISSN

1432-1238

Language

English

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

5

Publisher

SPRINGER

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Critical Care Medicine General & Internal Medicine COVID-19 Hypoxaemia Critical illness Corticosteroids Quality of life Mortality

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports